Massive Open Online Course on Stewardship

Program Objectives

This stewardship program aims to ensure appropriate utilization of antibiotics and improve infection prevention and control. 

What are the health needs and challenges?

Pfizer routinely sponsors and conducts medical education outreach to healthcare providers through a variety of mechanisms, including medical symposia and Pfizer sponsored preceptorships, to ensure appropriate utilization of antibiotics and improve infection prevention and control.

Description of partnership activities and how they address needs and challenges

Pfizer recently partnered with the British Society for Antimicrobial Chemotherapy and the University of Dundee to launch the Massive Open Online Course (MOOC) on antimicrobial stewardship. 

a) The course helps health care professionals understand and address the global threat of antimicrobial resistance, focusing on how to responsibly use high-quality antibiotics safely in everyday practice. 

b) Over 5,000 healthcare professionals had completed the course, with over 15,000 registrants. 

c) Pfizer currently provides support to BSAC for translation of the MOOC into Chinese and other languages to enable broader global access to AMS training.

Corresponding principle in the declaration

“We are committed to antibiotics only being used in patients who need them, we support continued education for clinical professionals on appropriate use, and we welcome the WHO Global Action Plan’s focus on improved stewardship”.

Read full Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance (AMR)

Partnership information

Company(ies) Pfizer

Partner(s) University of Dundee

Type of Partner(s) Academia / Hospitals

Therapeutic Focus Infectious Diseases

Disease(s) Drug-Resistant Infections (AMR)

Program Type(s) Health System Infrastructure - Training, Prevention Programs - Awareness & Outreach

Region(s) Europe & Central Asia

Number of Countries 1

Country(ies) United Kingdom

Start Date 2016

More information British Society for Antimicrobial Chemotherapy

Anticipated completion date Ongoing